GoodRx Holdings
GDRX
180 hedge funds and large institutions have $652M invested in GoodRx Holdings in 2022 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 45 increasing their positions, 56 reducing their positions, and 34 closing their positions.
18% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 34
3% more funds holding
Funds holding: 174 → 180 (+6)
4% more call options, than puts
Call options by funds: $5.64M | Put options by funds: $5.44M
20% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 56
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
21.51% less ownership
Funds ownership: 186.89% → 165.38% (-22%)
29% less capital invested
Capital invested by funds: $916M → $652M (-$264M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$9.12M |
| 2 |
NIP
Norwood Investment Partners
Mill Valley,
California
|
+$7.53M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$5.09M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.66M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$111M |
| 2 |
Renaissance Technologies
New York
|
-$6.46M |
| 3 |
GH
GAM Holding
Zurich,
Switzerland
|
-$5.09M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$3.75M |
| 5 |
EGM
Engineers Gate Manager
New York
|
-$3.16M |
GDRX Hedge Fund Activity: Q3 2022 in Review
180 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q3 2022, worth a combined $652M — down 29% from $916M a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new GDRX positions and 34 closed out — a net gain of 6 holders — while 45 added to existing stakes and 56 trimmed.
The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $9.12M. The largest seller was Morgan Stanley, cutting an estimated $111M.
- 180 institutional investors held GoodRx Holdings (GDRX) as of Q3 2022, up from 174 in Q2 2022.
- Funds reported $652M of GoodRx Holdings stock for Q3 2022, down 29% quarter-over-quarter.
- 40 funds opened new GoodRx Holdings positions in Q3 2022 and 34 closed out, a net change of +6 holders.
- The largest GoodRx Holdings buyer in Q3 2022 was Jacobs Levy Equity Management, an estimated $9.12M added.
- The largest GoodRx Holdings seller in Q3 2022 was Morgan Stanley, an estimated $111M sold.
Based on aggregated 13F filings for Q3 2022.